Cited by 3,047Cancer-related Molecular PathwaysDNA Repair MechanismsEffects of Radiation Exposure

The DOI matches its Crossref record; 59 of the 64 references it cites were found in a registry or an index.

A mammalian cell cycle checkpoint pathway utilizing p53 and GADD45 is defective in ataxia-telangiectasia

Kastan, Michael B., Zhan, Qimin, El-Deiry, Wafik S., Carrier, France, Jacks, Tyler, Walsh, William V., Plunkett, Beverly S., Vogelstein, Bert, Fornace, Albert J.·1992·Cell

DOI 10.1016/0092-8674(92)90593-2

Open this paper in CoChat — free account

Abstract

Cell cycle checkpoints can enhance cell survival and limit mutagenic events following DNA damage. Primary murine fibroblasts became deficient in a G1 checkpoint activated by ionizing radiation (IR) when both wild-type p53 alleles were disrupted. In addition, cells from patients with the radiosensitive, cancer-prone disease ataxia-telangiectasia (AT) lacked the IR-induced increase in p53 protein levels seen in normal cells. Finally, IR induction of the human GADD45 gene, an induction that is also defective in AT cells, was dependent on wild-type p53 function. Wild-type but not mutant p53 bound strongly to a conserved element in the GADD45 gene, and a p53-containing nuclear factor, which bound this element, was detected in extracts from irradiated cells. Thus, we identified three participants (AT gene(s), p53, and GADD45) in a signal transduction pathway that controls cell cycle arrest following DNA damage; abnormalities in this pathway probably contribute to tumor development.

Integrity signals

Registry

Crossref · 10.1016/0092-8674(92)90593-2

Cites

59 of 59 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Single-Step Method of RNA Isolation by Acid Guanidinium Thiocyanate–Phenol–Chloroform Extraction
Chomczynski, P., & Sacchi, N. (1987) · Analytical Biochemistry · doi:10.1006/abio.1987.9999 · Cited by 65,515
Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei
Dignam, J. D., Lebovitz, R. M., & Roeder, R. G. (1983) · Nucleic Acids Research · doi:10.1093/nar/11.5.1475 · Cited by 11,262
p53 Mutations in Human Cancers
Hollstein, M., Sidransky, D., Vogelstein, B., & Harris, C. C. (1991) · Science · doi:10.1126/science.1905840 · Cited by 8,018
Self-citation
Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours
Donehower, L. A., Harvey, M., Slagle, B. L., McArthur, M. J., Montgomery, C. A., Butel, J. S., & Bradley, A. (1992) · Nature · doi:10.1038/356215a0 · Cited by 4,649
The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53
Scheffner, M., Werness, B. A., Huibregtse, J. M., Levine, A. J., & Howley, P. M. (1990) · Cell · doi:10.1016/0092-8674(90)90409-8 · Cited by 3,995
The Causes of Cancer: Quantitative Estimates of Avoidable Risks of Cancer in the United States Today
Doll, R., & Peto, R. (1981) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/66.6.1192 · Cited by 3,927 · cited 1×
“Discussion Exposure to DNA-damaging agents probably contributes to the development of a significant percentage of human cancers (Doll and Peto, 1981).”
Background
Germ Line p53 Mutations in a Familial Syndrome of Breast Cancer, Sarcomas, and Other Neoplasms
Malkin, D., Li, F. P., Strong, L. C., Fraumeni, J. F., Nelson, C. E., Kim, D. H., Kassel, J., Gryka, M. A., Bischoff, F. Z., Tainsky, M. A., et al. (1990) · Science · doi:10.1126/science.1978757 · Cited by 3,765
Participation of p53 protein in the cellular response to DNA damage.
Kastan, M. B., Onyekwere, O. C., Sidransky, D., Vogelstein, B., & Craig, R. W. (1991) · PubMed · Cited by 3,761
Self-citation
The Causes of Cancer: Quantitative Estimates of Avoidable Risks of Cancer in the United States Today
Peto, R. (1983) · Springer eBooks · doi:10.1007/978-1-4757-1117-2_30 · Cited by 3,504
The mdm-2 oncogene product forms a complex with the p53 protein and inhibits p53-mediated transactivation
Momand, J., Zambetti, G. P., Olson, D. C., George, D., & Levine, A. J. (1992) · Cell · doi:10.1016/0092-8674(92)90644-r · Cited by 3,113

Show all 64 references

Sorted by citations

Items 801–900 of 1,007

The associations between Parkinson’s disease and cancer: the plot thickens
Feng, D. D., Cai, W., & Chen, X. M. (2015) · Translational Neurodegeneration · doi:10.1186/s40035-015-0043-z · Cited by 103
Genistein inactivates bcl-2, delays the G2/M phase of the cell cycle, and induces apoptosis of human breast adenocarcinoma MCF-7 cells
Constantinou, A. I., Kamath, N., & Murley, J. S. (1998) · European Journal of Cancer · doi:10.1016/s0959-8049(98)00198-1 · Cited by 104
Radiation-Induced p53 and p21WAF–1/CIP1 Expression in the Murine Intestinal Epithelium
Wilson, J. W., Pritchard, D. M., Hickman, J. A., & Potten, C. S. (1998) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)65631-3 · Cited by 102
p53-Dependent G1 arrest and p53-independent apoptosis influence the radiobiologic response of glioblastoma
Haas-Kogan, D. A., Yount, G. L., Haas, M., Levi, D., Kogan, S. C., Hu, L. J., Vidair, C. A., Deen, D. F., Dewey, W. C., & Israel, M. A. (1996) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/s0360-3016(96)00244-1 · Cited by 102
Involvement of p53 and p21 in Cellular Defects and Tumorigenesis in Atm−/− Mice
Xu, Y., Yang, E. M., Brugarolas, J., Jacks, T., & Baltimore, D. (1998) · Molecular and Cellular Biology · doi:10.1128/mcb.18.7.4385 · Cited by 103
Self-citation
A Human Homologue of the Schizosaccharomyces pombe rad1+ Checkpoint Gene Encodes an Exonuclease
Parker, A. E., de Weyer, I. V., Laus, M. C., van Oostveen, I., Yon, J. R., Verhasselt, P., & Luyten, W. H. M. L. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.29.18332 · Cited by 102
Development of a toxicogenomics signature for genotoxicity using a dose‐optimization and informatics strategy in human cells
Li, H., Hyduke, D. R., Chen, R., Heard, P. L., Yauk, C. L., Aubrecht, J., & Fornace, A. J. (2015) · Environmental and Molecular Mutagenesis · doi:10.1002/em.21941 · Cited by 108
Self-citation
Adaptive Response to DNA-Damaging Agents
Stecca, C., & GERBER, G. B. (1998) · Biochemical Pharmacology · doi:10.1016/s0006-2952(97)00448-6 · Cited by 102
Antifungal Activities of Antineoplastic Agents: Saccharomyces cerevisiae as a Model System To Study Drug Action
Cardenas, M. E., Cruz, M. C., Poeta, M. D., Chung, N., Perfect, J. R., & Heitman, J. (1999) · Clinical Microbiology Reviews · doi:10.1128/cmr.12.4.583 · Cited by 103
Structural evolution of C‐terminal domains in the p53 family
Ou, H. D., Löhr, F., Vogel, V., Mäntele, W., & Dötsch, V. (2007) · The EMBO Journal · doi:10.1038/sj.emboj.7601764 · Cited by 108
Regulation of insulin-like growth factor II P3 promotor by p53: a potential mechanism for tumorigenesis.
Zhang, L., Kashanchi, F., Zhan, Q., Zhan, S., Brady, J. N., Fornace, A. J., Seth, P. K., & Helman, L. J. (1996) · PubMed · Cited by 101
Self-citation
The Fanconi Anemia Polypeptide, FAC, Binds to the Cyclin-Dependent Kinase, cdc2
Kupfer, G. M., Yamashita, T., Näf, D., Suliman, A., Asano, S., & D’Andrea, A. D. (1997) · Blood · doi:10.1182/blood.v90.3.1047 · Cited by 102
Harmonising the response to DSBs: a new string in the ATM bow
Löbrich, M., & Jeggo, P. A. (2005) · DNA repair · doi:10.1016/j.dnarep.2004.12.008 · Cited by 102
Abnormal Expression of MDM2 in Prostate Carcinoma
Leite, K. R. M., de Franco, M. F., Srougi, M., Nesrallah, L., Nesrallah, A., Bevilacqua, R. G., Darini, E., Carvalho, C. M., Meirelles, M. I., Santana, I., et al. (2001) · Modern Pathology · doi:10.1038/modpathol.3880330 · Cited by 102
Mutation of Phosphoserine 389 Affects p53 Function in Vivo
Hao, M., Lowy, A. M., Kapoor, M., Deffie, A. M., Liu, G., & Lozano, G. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.46.29380 · Cited by 102
To be or not to be active: the stochastic nature of enhancer action
Fiering, S., Whitelaw, E., & Martin, D. I. K. (2000) · BioEssays · doi:10.1002/(sici)1521-1878(200004)22:4 · Cited by 161
Selective induction of p53 and chemosensitivity in RB-deficient cells by E1A mutants unable to bind the RB-related proteins
Samuelson, A. V., & Lowe, S. W. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.22.12094 · Cited by 102
The carboxyl-terminal domain of the p53 protein regulates sequence-specific DNA binding through its nonspecific nucleic acid-binding activity.
Bayle, J. H., Elenbaas, B., & Levine, A. J. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.12.5729 · Cited by 102
Monitoring and Signaling of Radiation-Induced Damage in Mammalian Cells
Szumiel, I. (1998) · Radiation Research · doi:10.2307/3579811 · Cited by 102
Testing the Role of p53 in the Expression of Genetic Instability and Apoptosis in Ataxia-telangiectasia
Meyn, M. S., Strasfeld, L. M., & Allen, C. (1994) · International Journal of Radiation Biology · doi:10.1080/09553009414551971 · Cited by 101
Gadd45 in the response of hematopoietic cells to genotoxic stress
Liebermann, D. A., & Hoffman‐Liebermann, B. (2007) · Blood Cells Molecules and Diseases · doi:10.1016/j.bcmd.2007.06.006 · Cited by 99
Opposite Effect of NF-κB and c-Jun N-terminal Kinase on p53-independent GADD45 Induction by Arsenite
Chen, F., Lu, Y., Zhang, Z., Vallyathan, V., Ding, M., Castranova, V., & Shi, X. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m011682200 · Cited by 101
Human cytomegalovirus elevates levels of the cellular protein p53 in infected fibroblasts
Muganda, P. M., Mendoza, O., Hernandez, J., & Qian, Q. (1994) · Journal of Virology · doi:10.1128/jvi.68.12.8028-8034.1994 · Cited by 101
p53 and Sp1 Interact and Cooperate in the Tumor Necrosis Factor-induced Transcriptional Activation of the HIV-1 Long Terminal Repeat
Gualberto, A., & Baldwin, A. S. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.34.19680 · Cited by 101
p53 immunohistochemical analysis in breast cancer with four monoclonal antibodies: comparison of staining and PCR-SSCP results
Jacquemier, J. D., Molès, J., Penault-Llorca, F. M., Adélaı̈de, J., Torrente, M., Viens, P., Birnbaum, D., & Theillet, C. G. (1994) · British Journal of Cancer · doi:10.1038/bjc.1994.164 · Cited by 101
How cancer cells hijack DNA double-strand break repair pathways to gain genomic instability
Jeggo, P. A., & Löbrich, M. (2015) · Biochemical Journal · doi:10.1042/bj20150582 · Cited by 108
DNA damage increases sensitivity to vinca alkaloids and decreases sensitivity to taxanes through p53-dependent repression of microtubule-associated protein 4.
Zhang, C. C., Yang, J., Bash-Babula, J., White, E., Murphy, M. E., Levine, A. J., & Hait, W. N. (1999) · PubMed · Cited by 100
p53-Mediated Regulation of Proliferating Cell Nuclear Antigen Expression in Cells Exposed to Ionizing Radiation
Xu, J., & Morris, G. F. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.1.12 · Cited by 102
Questioning the Role of Checkpoint Kinase 2 in the p53 DNA Damage Response
Ahn, J., Urist, M., & Prives, C. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m213185200 · Cited by 99
Synthesis of new thiazolo-pyrrolidine–(spirooxindole) tethered to 3-acylindole as anticancer agents
Islam, M. S., Ghawas, H. M., El‐Senduny, F. F., Al‐Majid, A. M., Elshaier, Y. A. M. M., Badria, F. A.-E., & Barakat, A. (2018) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2018.10.036 · Cited by 99
The proteasome inhibitor bortezomib stabilizes a novel active form of p53 in human LNCaP-Pro5 prostate cancer cells.
Williams, S. A., & McConkey, D. J. (2003) · PubMed · Cited by 99
Identification of Several Human Homologs of Hamster DNA Damage-inducible Transcripts
Sheikh, M. S., Carrier, F., Papathanasiou, M. A., Hollander, M. C., Zhan, Q., Yu, K. J., & Fornace, A. J. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.42.26720 · Cited by 99
Self-citation
Interaction of CR6 (GADD45γ) with Proliferating Cell Nuclear Antigen Impedes Negative Growth Control
Azam, N., Vairapandi, M., Zhang, W., Hoffman‐Liebermann, B., & Liebermann, D. A. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m005626200 · Cited by 99
Redox state regulates binding of p53 to sequence-specific DNA, but not to non-specific or mismatched DNA
Parks, D. (1997) · Nucleic Acids Research · doi:10.1093/nar/25.6.1289 · Cited by 100
Gas1-Induced Growth Suppression Requires a Transactivation-Independent p53 Function
Sal, G. D., Ruaro, E. M., Utrera, R., Cole, C. N., Levine, A. J., & Schneider, C. (1995) · Molecular and Cellular Biology · doi:10.1128/mcb.15.12.7152 · Cited by 98
ATR Is Not Required for p53 Activation but Synergizes with p53 in the Replication Checkpoint
Nghiem, P., Park, P. K., Kim, Y.-S., Desai, B. N., & Schreiber, S. L. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m106113200 · Cited by 99
Aberrant regulation and function of wild-type p53 in radioresistant melanoma cells.
Satyamoorthy, K., Chehab, N. H., Waterman, M. J. F., Lien, M. C., El‐Deiry, W. S., Herlyn, M., & Halazonetis, T. D. (2000) · PubMed · Cited by 98
Self-citation
Role of Human Cds1 (Chk2) Kinase in DNA Damage Checkpoint and Its Regulation by p53
Tominaga, K., Morisaki, H., Kaneko, Y. S., Fujimoto, A., Tanaka, T., Ohtsubo, M., Hirai, M., Okayama, H., Ikeda, K., & Nakanishi, M. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.44.31463 · Cited by 101
Transgenic mouse models that explore the multistep hypothesis of intestinal neoplasia.
Kim, S. H., Roth, K. A., Moser, A. R., & Gordon, J. I. (1993) · The Journal of Cell Biology · doi:10.1083/jcb.123.4.877 · Cited by 99
RB signaling prevents replication-dependent DNA double-strand breaks following genotoxic insult
Bosco, E. E. (2004) · Nucleic Acids Research · doi:10.1093/nar/gkg919 · Cited by 97
GADD45 Regulates G2/M Arrest, DNA Repair, and Cell Death in Keratinocytes Following Ultraviolet Exposure
Maeda, T., Hanna, A. N., Sim, A. B., Chua, P., Chong, M. T., & Tron, V. A. (2002) · Journal of Investigative Dermatology · doi:10.1046/j.1523-1747.2002.01781.x · Cited by 96
Gadd45a contributes to p53 stabilization in response to DNA damage
Jin, S., Mazzacurati, L., Zhu, X., Tong, T., Song, Y., Shao, S., Petrik, K. L., Rajasekaran, B., Wu, M., & Zhan, Q. (2003) · Oncogene · doi:10.1038/sj.onc.1206907 · Cited by 99
Self-citation
ATM prevents DSB formation by coordinating SSB repair and cell cycle progression
Khoronenkova, S. V., & Dianov, G. L. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1416031112 · Cited by 111
Yeast and Cancer
Hartwell, L. H. (2004) · Bioscience Reports · doi:10.1007/s10540-005-2743-6 · Cited by 97
MCG10, a Novel p53 Target Gene That Encodes a KH Domain RNA-Binding Protein, Is Capable of Inducing Apoptosis and Cell Cycle Arrest in G2-M
Zhu, J., & Chen, X. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.15.5602-5618.2000 · Cited by 99
Specificity of PCR-based clonality analysis of immunoglobulin heavy chain gene rearrangements for the detection of bone marrow involvement by low-grade B-cell lymphomas
Brinckmann, R., Kaufmann, O., Reinartz, B., & Dietel, M. (2000) · The Journal of Pathology · doi:10.1002/(sici)1096-9896(200001)190:1 · Cited by 21
Phosphorylation of the replication protein A large subunit in the Saccharomyces cerevisiae checkpoint response
Brush, G. S. (2000) · Nucleic Acids Research · doi:10.1093/nar/28.19.3725 · Cited by 98
Targeting the mouse genome: a compendium of knockouts (part II)
Brandon, E. P., Idzerda, R. L., & McKnight, G. S. (1995) · Current Biology · doi:10.1016/s0960-9822(95)00152-7 · Cited by 97
Identification of novel direct transcriptional targets of glucocorticoid receptor
U, M., Shen, L., Oshida, T., Miyauchi, J., Yamada, M., & Miyashita, T. (2004) · Leukemia · doi:10.1038/sj.leu.2403516 · Cited by 97
Partial Rescue of Ethanol-Induced Neuronal Apoptosis by Growth Factor Activation of Phosphoinositol-3-Kinase
de la Monte, S. M., Ganju, N., Banerjee, K., Brown, N. V., Luong, T., & Wands, J. R. (2000) · Alcoholism Clinical and Experimental Research · doi:10.1111/j.1530-0277.2000.tb02044.x · Cited by 97
Intercellular adhesions as determinants of tissue assembly and malignant invasion
Steinberg, M. S., & Foty, R. A. (1997) · Journal of Cellular Physiology · doi:10.1002/(sici)1097-4652(199711)173:2 · Cited by 43
Formation of 8-hydroxydeoxyguanosine and cell-cycle arrest in the rat liver via generation of oxidative stress by phenobarbital: association with expression profiles of p21WAF1/Cip1, cyclin D1 and Ogg1
Kakehashi, A., Wanibuchi, H., Imaoka, S., Ogawa, M., Masuda, C., Morimura, K., Funae, Y., & Fukushima, S. (2002) · Carcinogenesis · doi:10.1093/carcin/23.2.341 · Cited by 98
Tumor hypoxia and heterogeneity: Challenges and opportunities for the future
Sutherland, R. M., Ausserer, W. A., Murphy, B. J., & Laderoute, R. R. (1996) · Seminars in Radiation Oncology · doi:10.1016/s1053-4296(96)80036-1 · Cited by 98
Catalase Protects HepG2 Cells from Apoptosis Induced by DNA-damaging Agents by Accelerating the Degradation of p53
Bai, J., & Cederbaum, A. I. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m206273200 · Cited by 96
Early Embryonic Lethality in PARP-1 AtmDouble-Mutant Mice Suggests a Functional Synergy in Cell Proliferation during Development
Murcia, J. M., Mark, M. P., Wendling, O., Wynshaw-Boris, A. J., & de MURCIA, G. (2001) · Molecular and Cellular Biology · doi:10.1128/mcb.21.5.1828-1832.2001 · Cited by 96
Activation of Src-like p56/p53lyn tyrosine kinase by ionizing radiation.
Kharbanda, S., Yuan, Z., Rubin, E. H., Weichselbaum, R. R., & Kufe, D. W. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)32054-9 · Cited by 96
V(D)J recombination and the cell cycle
Lin, W.-C., & Desiderio, S. V. (1995) · Immunology Today · doi:10.1016/0167-5699(95)80182-0 · Cited by 97
Negative Cell Cycle Regulation and DNA Damage-inducible Phosphorylation of the BRCT Protein 53BP1
Xia, Z., Morales, J. C., Dunphy, W. G., & Carpenter, P. B. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m007665200 · Cited by 96
Tumor Suppressor Activity of AP2α Mediated through a Direct Interaction with p53
McPherson, L. A., Loktev, A. V., & Weigel, R. J. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m208924200 · Cited by 95
The N-Terminal Domain of p73 Interacts with the CH1 Domain of p300/CREB Binding Protein and Mediates Transcriptional Activation and Apoptosis
Zeng, X., Li, X., Miller, A., Yuan, Z.-M., Yuan, W., Kwok, R. P. S., Goodman, R. H., & Lu, H. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.4.1299-1310.2000 · Cited by 97
Role for p300 in Stabilization of p53 in the Response to DNA Damage
Yuan, Z.-M., Huang, Y., Ishiko, T., Nakada, S., Utsugisawa, T., Shioya, H., Utsugisawa, Y., Yokoyama, K. K., Weichselbaum, R. R., Shi, Y., et al. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.4.1883 · Cited by 97
Allosteric Regulation of the Thermostability and DNA Binding Activity of Human p53 by Specific Interacting Proteins
Hansen, S., Hupp, T. R., & Lane, D. P. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.7.3917 · Cited by 96
Molecular foundations of cancer: New targets for intervention
Karp, J. E., & Broder, S. E. (1995) · Nature Medicine · doi:10.1038/nm0495-309 · Cited by 96
Cytokine rescue of p53-dependent apoptosis and cell cycle arrest is mediated by distinct Jak kinase signaling pathwaysPreprint
Quelle, F. W., Wang, J., Feng, J., Wang, D., Cleveland, J. L., Ihle, J. N., & Zambetti, G. P. (1998) · Genes & Development · doi:10.1101/gad.12.8.1099 · Cited by 96
Tumor suppressor p53 dependent recruitment of nucleotide excision repair factors XPC and TFIIH to DNA damage
Wang, Q. (2003) · DNA repair · doi:10.1016/s1568-7864(03)00002-8 · Cited by 97
Linalool preferentially induces robust apoptosis of a variety of leukemia cells via upregulating p53 and cyclin-dependent kinase inhibitors
Gu, Y., Zhang, T., Qiu, X., Zhang, X., Gan, X., Fang, Y., Xu, X., & Xu, R. (2009) · Toxicology · doi:10.1016/j.tox.2009.11.013 · Cited by 95
Aging and cancer: The role of stromal interactions with epithelial cells
Rinehart, C. A., & Torti, V. R. (1997) · Molecular Carcinogenesis · doi:10.1002/(sici)1098-2744(199704)18:4 · Cited by 45
Dissection of the genetic programs of p53-mediated G1 growth arrest and apoptosis: blocking p53-induced apoptosis unmasks G1 arrest
Guillouf, C., Graña, X., Selvakumaran, M., Luca, A. D., Giordano, A., Hoffman‐Liebermann, B., & Liebermann, D. A. (1995) · Blood · doi:10.1182/blood.v85.10.2691.bloodjournal85102691 · Cited by 95
Regulation of Mutant p53 Temperature-sensitive DNA Binding
Friedlander, P. A., Legros, Y., Soussi, T., & Prives, C. L. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.41.25468 · Cited by 94
Wild Type and Mutant p53 Differentially Regulate the Gene Expression of Human Collagenase-3 (hMMP-13)
Sun, Y., Cheung, J. M., Martel‐Pelletier, J., Pelletier, J. P., Wenger, L., Altman, R. D., Howell, D. S., & Cheung, H. S. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.15.11327 · Cited by 97
Mutations Revealed by Sequencing the 5' Half of the Gene for Ataxia Telangiectasia
Byrd, P. J., McConville, C. M., Cooper, P. R., Parkhill, J., Stanković, T., McGuire, G. M., Thick, J. A., & Taylor, A. M. R. (1996) · Human Molecular Genetics · doi:10.1093/hmg/5.1.145 · Cited by 95
The role of the p53 protein in the selective vulnerability of the inner retina to transient ischemia.
Rosenbaum, D. M., Rosenbaum, P. S., Gupta, H., Singh, M., Aggarwal, A., Hall, D. H., Roth, S., & Kessler, J. A. (1998) · PubMed · Cited by 93
p53-Mediated down-regulation of the human DNA repair gene O6-methylguanine-DNA methyltransferase (MGMT) via interaction with Sp1 transcription factor.
Bocangel, D., Sengupta, S., MITRA, S. P., & Bhakat, K. K. (2009) · PubMed · Cited by 94
Mdm2 in the Response to Radiation
Perry, M. E. (2004) · Molecular Cancer Research · doi:10.1158/1541-7786.9.2.1 · Cited by 96
Complementation by Wild-Type p53 of Interleukin-6 Effects on M1 Cells: Induction of Cell Cycle Exit and Cooperativity with c- myc Suppression
Levy-Strumpf, N., Yonish-Rouach, E., Oren, M., & Kimchi, A. (1993) · Molecular and Cellular Biology · doi:10.1128/mcb.13.12.7942-7952.1993 · Cited by 95
Induction of Squamous Cell Carcinoma in p53-Deficient Mice after Ultraviolet Irradiation
Li, G., Tron, V. A., & HO, V. C. (1998) · Journal of Investigative Dermatology · doi:10.1046/j.1523-1747.1998.00090.x · Cited by 91
Murine Double Minute (MDM2) Blocks p53-coactivator Interaction, a New Mechanism for Inhibition of p53-dependent Gene Expression
Wadgaonkar, R., & Collins, T. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.20.13760 · Cited by 97
Ubiquitin, E6-AP, and Their Role in p53 Inactivation
Scheffner, M. (1998) · Pharmacology & Therapeutics · doi:10.1016/s0163-7258(98)00003-5 · Cited by 93
Selenium compounds regulate p53 by common and distinctive mechanisms.
Smith, M. L., Lancia, J. K., Mercer, T. I., & Ip, C. (2004) · PubMed · Cited by 93
p53 and IGFBP-3: Apoptosis and Cancer Protection
Grimberg, A. (2000) · Molecular Genetics and Metabolism · doi:10.1006/mgme.2000.3008 · Cited by 96
Concomitant p53 gene mutation and increased radiosensitivity in rat lung embryo epithelial cells during neoplastic development.
Biard, D. S. F., Martin, M. T., Rhun, Y. L., Duthu, A., Lefaix, J.-L., May, E., & May, P. (1994) · PubMed · Cited by 93
Activated H-ras Rescues E1A-Induced Apoptosis and Cooperates with E1A To Overcome p53-Dependent Growth Arrest
Lin, H.-J. L., Eviner, V. T., Prendergast, G. C., & White, E. (1995) · Molecular and Cellular Biology · doi:10.1128/mcb.15.8.4536 · Cited by 94
The DNA damage response in DNA-dependent protein kinase-deficient SCID mouse cells: Replication protein A hyperphosphorylation and p53 induction
Fried, L. M., Koumenis, C., Peterson, S., Green, S., van Zijl, P., Allalunis‐Turner, J., Chen, D. J., Fishel, R. A., Giaccia, A. J., Brown, J. M., et al. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.24.13825 · Cited by 94
The p53 circuit board
Sullivan, K. D., Gallant‐Behm, C. L., Henry, R. E., Fraikin, J.-L., & Espinosa, J. M. (2012) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2012.01.004 · Cited by 96
Oligomerization of BAK by p53 Utilizes Conserved Residues of the p53 DNA Binding Domain
Pietsch, E. C., Perchiniak, E. M., Canutescu, A. A., Wang, G., Dunbrack, R. L., & Murphy, M. E. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m710539200 · Cited by 94
The interplay of NR4A receptors and the oncogene–tumor suppressor networks in cancer
Beard, J. A., Tenga, A., & Chen, T. (2014) · Cellular Signalling · doi:10.1016/j.cellsig.2014.11.009 · Cited by 94
ATP Activates Ataxia-Telangiectasia Mutated (ATM) in Vitro
Kozlov, S., Gueven, N., Keating, K. E., Ramsay, J., & Lavin, M. F. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m300003200 · Cited by 91
Apoptosis in liver disease
Galle, P. R. (1997) · Journal of Hepatology · doi:10.1016/s0168-8278(97)80189-4 · Cited by 92
Activation of p53 and its target genes p21WAF1/Cip1 and PAG608/Wig-1 in ischemic preconditioning
Tomasevic, G., Shamloo, M., Israeli, D., & Wieloch, T. W. (1999) · Molecular Brain Research · doi:10.1016/s0169-328x(99)00146-1 · Cited by 91
Genetic pathway to recurrent chromosome translocations in murine lymphoma involves V(D)J recombinase
Vanasse, G. J., Halbrook, J., Thomas, S., Burgess, A., Hoekstra, M. F., Distèche, C. M., & Willerford, D. M. (1999) · Journal of Clinical Investigation · doi:10.1172/jci6658 · Cited by 89
p53 Regulates the Minimal Promoter of the Human Topoisomerase II Gene
Sandri, M., Isaacs, R., Ongkeko, W. M., Harris, A. L., Hickson, I. D., Broggini, M., & Vikhanskaya, F. (1996) · Nucleic Acids Research · doi:10.1093/nar/24.22.4464 · Cited by 88
The tumor suppressor protein p53 strongly alters human immunodeficiency virus type 1 replication
Duan, L., Ozaki, I., Oakes, J. W., Taylor, J. P., Khalili, K., & Pomerantz, R. J. (1994) · Journal of Virology · doi:10.1128/jvi.68.7.4302-4313.1994 · Cited by 92
Poly(ADP-ribosyl)ation of p53 during apoptosis in human osteosarcoma cells.
Simbulan-Rosenthal, C. M., Rosenthal, D. S., Luo, R., & Smulson, M. E. (1999) · PubMed · Cited by 91
BRCA1 activation of the GADD45 promoter
Jin, S., Zhao, H., Fan, F., Blanck, P., Fan, W., Colchagie, A. B., Fornace, A. J., & Zhan, Q. (2000) · Oncogene · doi:10.1038/sj.onc.1203759 · Cited by 91
Self-citation
The complexity of radiation stress responses: analysis by informatics and functional genomics approaches.
Fornace, A. J., Amundson, S. A., Bittner, M. L., Myers, T. G., Meltzer, P. S., Weinsten, J. N., & Trent, J. M. (1999) · Europe PMC (PubMed Central) · Cited by 90
Self-citation
Staf50 is a novel p53 target gene conferring reduced clonogenic growth of leukemic U-937 cells
Obad, S., Brunnström, H., Vallon-Christersson, J., Borg, Å., Drott, K., & Gullberg, U. (2004) · Oncogene · doi:10.1038/sj.onc.1207524 · Cited by 90
The Future of Radiobiology
Kirsch, D. G., Diehn, M., Kesarwala, A. H., Maity, A. M., Morgan, M. A., Schwarz, J. K., Bristow, R. G., Demaria, S., Eke, I., Griffin, R. J., et al. (2017) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djx231 · Cited by 96
A Common Set of Immediate–Early Response Genes in Liver Regeneration and Hyperplasia
Locker, J. D., Tian, J., Carver, R. S., Concas, D., Cossu, C., Ledda‐Columbano, G. M., & Columbano, A. (2003) · Hepatology · doi:10.1053/jhep.2003.50299 · Cited by 90
P73 functionally replaces p53 in Adriamycin‐treated, p53‐deficient breast cancer cells
Vayssade, M., Haddada, H., Faridoni‐Laurens, L., Tourpin, S., Valent, A., Bénard, J., & Ahomadegbe, J. (2005) · International Journal of Cancer · doi:10.1002/ijc.21033 · Cited by 90
Absence of p53 Mutations in Malignant Mesotheliomas
Mor, O., Yaron, P., Huszar, M., Yellin, A., Jakobovitz-Picard, O., Brok‐Simoni, F., Rechavi, G., & Reichert, N. (1997) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/ajrcmb.16.1.8998073 · Cited by 90

Authors: Kastan, M. B., Zhan, Q., El-Deiry, W. S., Carrier, F., Jacks, T., Walsh, W. V., Plunkett, B. S., Vogelstein, B., & Fornace, A. J.
Affiliations: Johns Hopkins University (US)
National Cancer Institute (US)
Massachusetts Institute of Technology (US)
ORCID: Kastan, Michael B.
Zhan, Qimin
Carrier, France
Jacks, Tyler
Vogelstein, Bert
Fornace, Albert J.
Venue: Cell
Publisher: Elsevier BV
Published: 1992-11
Volume: 71
Issue: 4
Pages: 587-597
ISSN: 0092-8674 (ISSN-L)
DOI: 10.1016/0092-8674(92)90593-2
OpenAlex: W1986179131
Cited by: 3,047
References: 64
Citations by year: 2026: 11 · 2025: 16 · 2024: 17 · 2023: 20 · 2022: 23 · 2021: 23 · 2020: 24 · 2019: 16 · 2018: 31 · 2017: 34 · 2016: 35 · 2015: 43 · 2014: 44 · 2013: 30 · 2012: 48
FWCI: 86.58
Type: journal article
Language: en
Open access: closed
Licence: www.elsevier.com/tdm/userlicense/1.0/ (tdm)
Locations: Cell (publishedVersion)
PubMed (publishedVersion)
Funders: National Cancer Institute (CA 09071, CA43460, T32CA009071)
National Institute of Environmental Health Sciences (ES05777)
Topics: Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › DNA Repair Mechanisms
Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › Effects of Radiation Exposure
Keywords: ataxia telangiectasia, p53, GADD45, cell cycle checkpoints, G1/S checkpoint, ionizing radiation, DNA damage response, cell cycle arrest, signal transduction, cancer susceptibility, radiosensitivity
MeSH terms: Amino Acid Sequence, Animals, Ataxia Telangiectasia, Base Sequence, Cell Cycle, Cell Line, Cloning, Molecular, DNA Damage, DNA Repair, Gene Expression Regulation, Humans, Molecular Sequence Data, Genes, p53, Mutagenesis, Mice

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

A mammalian cell cycle checkpoint pathway utilizing p53 and GADD45 is defective in ataxia-telangiectasia

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks